These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

273 related articles for article (PubMed ID: 23360785)

  • 21. Gene expression profiling of primary cutaneous melanoma and clinical outcome.
    Winnepenninckx V; Lazar V; Michiels S; Dessen P; Stas M; Alonso SR; Avril MF; Ortiz Romero PL; Robert T; Balacescu O; Eggermont AM; Lenoir G; Sarasin A; Tursz T; van den Oord JJ; Spatz A;
    J Natl Cancer Inst; 2006 Apr; 98(7):472-82. PubMed ID: 16595783
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-143, miR-222, and miR-452 are useful as tumor stratification and noninvasive diagnostic biomarkers for bladder cancer.
    Puerta-Gil P; García-Baquero R; Jia AY; Ocaña S; Alvarez-Múgica M; Alvarez-Ossorio JL; Cordon-Cardo C; Cava F; Sánchez-Carbayo M
    Am J Pathol; 2012 May; 180(5):1808-15. PubMed ID: 22426337
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Chromogenic in situ hybridization analysis of melastatin mRNA expression in melanomas from American Joint Committee on Cancer stage I and II patients with recurrent melanoma.
    Hammock L; Cohen C; Carlson G; Murray D; Ross JS; Sheehan C; Nazir TM; Carlson JA
    J Cutan Pathol; 2006 Sep; 33(9):599-607. PubMed ID: 16965333
    [TBL] [Abstract][Full Text] [Related]  

  • 24. The miRNA machinery in primary cutaneous malignant melanoma, cutaneous malignant melanoma metastases and benign melanocytic nevi.
    Sand M; Skrygan M; Georgas D; Sand D; Gambichler T; Altmeyer P; Bechara FG
    Cell Tissue Res; 2012 Oct; 350(1):119-26. PubMed ID: 22706980
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Overexpression of Lerk-5/Eplg5 messenger RNA: a novel marker for increased tumorigenicity and metastatic potential in human malignant melanomas.
    Vogt T; Stolz W; Welsh J; Jung B; Kerbel RS; Kobayashi H; Landthaler M; McClelland M
    Clin Cancer Res; 1998 Mar; 4(3):791-7. PubMed ID: 9533549
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vascular endothelial growth factor C mRNA expression correlates with stage of progression in patients with melanoma.
    Goydos JS; Gorski DH
    Clin Cancer Res; 2003 Dec; 9(16 Pt 1):5962-7. PubMed ID: 14676121
    [TBL] [Abstract][Full Text] [Related]  

  • 27. miR-145 overexpression suppresses the migration and invasion of metastatic melanoma cells.
    Dynoodt P; Speeckaert R; De Wever O; Chevolet I; Brochez L; Lambert J; Van Gele M
    Int J Oncol; 2013 Apr; 42(4):1443-51. PubMed ID: 23404256
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Dipeptidyl peptidase II is not a marker for progression in melanoma.
    Fröhlich E; Maier E; Mack AF; Garbe C
    J Dermatol Sci; 2009 Jan; 53(1):68-71. PubMed ID: 18823758
    [No Abstract]   [Full Text] [Related]  

  • 29. MicroRNA profiling of benign and malignant pheochromocytomas identifies novel diagnostic and therapeutic targets.
    Meyer-Rochow GY; Jackson NE; Conaglen JV; Whittle DE; Kunnimalaiyaan M; Chen H; Westin G; Sandgren J; Stålberg P; Khanafshar E; Shibru D; Duh QY; Clark OH; Kebebew E; Gill AJ; Clifton-Bligh R; Robinson BG; Benn DE; Sidhu SB
    Endocr Relat Cancer; 2010 Sep; 17(3):835-46. PubMed ID: 20621999
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dysregulation of microRNAs in adrenocortical tumors.
    Singh P; Soon PS; Feige JJ; Chabre O; Zhao JT; Cherradi N; Lalli E; Sidhu SB
    Mol Cell Endocrinol; 2012 Mar; 351(1):118-28. PubMed ID: 21996374
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Genetic variations of microRNAs in human cancer and their effects on the expression of miRNAs.
    Wu M; Jolicoeur N; Li Z; Zhang L; Fortin Y; L'Abbe D; Yu Z; Shen SH
    Carcinogenesis; 2008 Sep; 29(9):1710-6. PubMed ID: 18356149
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Pivotal MicroRNAs in Melanoma: A Mini-Review.
    Deng Z; Hao J; Lei D; He Y; Lu L; He L
    Mol Diagn Ther; 2016 Oct; 20(5):449-55. PubMed ID: 27351922
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Transcriptomic identification of miR-205 target genes potentially involved in metastasis and survival of cutaneous malignant melanoma.
    Sánchez-Sendra B; Serna E; Navarro L; González-Muñoz JF; Portero J; Ramos A; Murgui A; Monteagudo C
    Sci Rep; 2020 Mar; 10(1):4771. PubMed ID: 32179834
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Patterns of melastatin mRNA expression in melanocytic tumors.
    Deeds J; Cronin F; Duncan LM
    Hum Pathol; 2000 Nov; 31(11):1346-56. PubMed ID: 11112208
    [TBL] [Abstract][Full Text] [Related]  

  • 35. [Oncogenic and tumour suppressor microRNAs].
    Finoux AL; Chartrand P
    Med Sci (Paris); 2008 Dec; 24(12):1049-54. PubMed ID: 19116113
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Melanoma gene expression and clinical course.
    Vourc'h-Jourdain M; Volteau C; Nguyen JM; Khammari A; Dreno B
    Arch Dermatol Res; 2009 Oct; 301(9):673-9. PubMed ID: 19326132
    [TBL] [Abstract][Full Text] [Related]  

  • 37. MicroRNAs as prognostic markers in ovarian cancer.
    Llauradó M; Majem B; Altadill T; Lanau L; Castellví J; Sánchez-Iglesias JL; Cabrera S; De la Torre J; Díaz-Feijoo B; Pérez-Benavente A; Colás E; Olivan M; Doll A; Alameda F; Matias-Guiu X; Moreno-Bueno G; Carey MS; Del Campo JM; Gil-Moreno A; Reventós J; Rigau M
    Mol Cell Endocrinol; 2014 Jun; 390(1-2):73-84. PubMed ID: 24747602
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Coexpression of bone sialoprotein (BSP) and the pivotal transcriptional regulator of osteogenesis, Cbfa1/Runx2, in malignant melanoma.
    Riminucci M; Corsi A; Peris K; Fisher LW; Chimenti S; Bianco P
    Calcif Tissue Int; 2003 Sep; 73(3):281-9. PubMed ID: 14667142
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Genome-Wide Screen for MicroRNAs Reveals a Role for miR-203 in Melanoma Metastasis.
    Lohcharoenkal W; Das Mahapatra K; Pasquali L; Crudden C; Kular L; Akkaya Ulum YZ; Zhang L; Xu Landén N; Girnita L; Jagodic M; Ståhle M; Sonkoly E; Pivarcsi A
    J Invest Dermatol; 2018 Apr; 138(4):882-892. PubMed ID: 29104160
    [TBL] [Abstract][Full Text] [Related]  

  • 40. miR in melanoma development: miRNAs and acquired hallmarks of cancer in melanoma.
    Bennett PE; Bemis L; Norris DA; Shellman YG
    Physiol Genomics; 2013 Nov; 45(22):1049-59. PubMed ID: 24046283
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.